This website uses cookies to enhance the user experience.
HL

Haakon Lude Sande1978

Shareholdings
5
16
Norway Business roles
12

Roles

Management

NameRoleTotal operating incomeTotal equityShares
H
HALSA INVEST AS
Managing Director/CEO
-
-
100 %
directly
Managing Director/CEO
28,925,398
1,000,000
33.33 %
indirectly
S
SANDE HOLDING AS
Managing Director/CEO
-
-
33.33 %
indirectly
S
SANDE HOLDING AS
Managing Director/CEO
5,506,200
5,577,114
33.3 %
directly

Boards

NameRoleTotal operating incomeTotal equityShares
H
HALSA INVEST AS
Chairman
-
-
100 %
directly
Board Member
28,925,398
1,000,000
33.33 %
indirectly
U
ULRIKSDAL 1 AS
Board Member
8,571,252
997,510
33.33 %
indirectly
C
CRUISESPESIALISTEN AS
Board Member
53,690,894
1,626,352
33.33 %
indirectly
S
SANDE HOLDING AS
Chairman
-
-
33.33 %
indirectly
S
SANDE HOLDING AS
Chairman
5,506,200
5,577,114
33.3 %
directly
Z
ZERACRYL AS
Board Member
404,564
2,931,398
6.27 %
indirectly
D
DLS AS
Chairman
552,469
11,973,547
-
Last update: Nov 30, 2024

Shares owned by Haakon Lude Sande

NameShare classTotal operating incomeTotal equityShare
S
SANDE HOLDING AS
B-aksjer
5,506,200
5,577,114
33.3 %
directly
R
RECEIPTS AS
Ordinære aksjer
2,300,000
-6,165,029
0.7 %
directly 0.7 %
indirectly 0.62 %
H
HALSA INVEST AS
B-aksjer
A-aksjer
-
-
-
-
99.9 %
directly 100 %
0.1 %
directly 100 %
28,925,398
1,000,000
33.33 %
indirectly
U
ULRIKSDAL 1 AS
8,571,252
997,510
33.33 %
indirectly
C
CRUISESPESIALISTEN AS
53,690,894
1,626,352
33.33 %
indirectly
S
SANDE HOLDING AS
-
-
33.33 %
indirectly
N
NAPRAPAT IVERSEN AS
0
-44,689
33.3 %
indirectly
Z
ZERACRYL AS
404,564
2,931,398
6.27 %
indirectly
Z
ZNL ENERGY AS
0
10,150,926
0.85 %
indirectly
F
FRIENDR AS
0
10,392,613
0.7 %
indirectly
X
XRT INVEST AS
0
4,296,069
0.69 %
indirectly
0
14,878
0.68 %
indirectly
B
BERGEN CARBON SOLUTIONS AS
116,000
184,385,000
0.68 %
indirectly
0
17,488
0.68 %
indirectly
B
BCS HØYANGER AS
0
-57,507
0.68 %
indirectly
0
17,492
0.68 %
indirectly
B
BUSINESSCLASS.COM AS
690,800
21,672,479
0.65 %
indirectly
D
DIMEQ AS
982,323
9,301,437
0.65 %
indirectly
I
IMMUNOPHARMA AS
NO0010735335
14,110,340
195,301,042
0.03 %
directly < 0.01 %

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025